Alexander Hardy - 29 Nov 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
29 Nov 2024
Net transactions value
-$927,097
Form type
4
Filing time
03 Dec 2024, 18:15:02 UTC
Previous filing
19 Mar 2024
Next filing
18 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $16,802 +300 +0.2% $56.01 148,451 31 Oct 2024 Direct F1
transaction BMRN Common Stock Tax liability $943,899 -14,295 -9.6% $66.03 134,156 29 Nov 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan.